Gibson Oncology

0 followers


Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.

Employees

1-10

Links

Org chart

Randall B Riggs
President & CEO

Randall B Riggs

Collapse
Elizabeth L Rogers
Founder & Board Member, COO
Theodore C Solomon
Founder & Board Member, CFO
Clifford T Solomon
Founder & Board Member, CMO

Board & advisors

Mark C Rogers
Founder & Board Member Executive Chair
Fred Mermelstein
Board Member
Mark D. Baganz
Board Member
Michael Zinner
Scientific Advisor
Graeme F. Woodworth
Scientific Advisor
Pooran Chand
Scientific Advisor
Desmond A. Brown
Scientific Advisor
Danzhou Yang
Scientific Advisor
Mark S Cushman
Scientific Advisor